rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2010-7-12
|
pubmed:abstractText |
Cell regulatory G2/M phase proteins are the key regulators of mitosis and have been reported with abnormal expressions in various malignancies.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1998-4138
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
167-71
|
pubmed:dateRevised |
2011-11-2
|
pubmed:meshHeading |
pubmed-meshheading:20622363-Adult,
pubmed-meshheading:20622363-Aged,
pubmed-meshheading:20622363-Blotting, Western,
pubmed-meshheading:20622363-Case-Control Studies,
pubmed-meshheading:20622363-Cell Cycle Proteins,
pubmed-meshheading:20622363-Cell Division,
pubmed-meshheading:20622363-Cervical Intraepithelial Neoplasia,
pubmed-meshheading:20622363-Cyclin B1,
pubmed-meshheading:20622363-Female,
pubmed-meshheading:20622363-G2 Phase,
pubmed-meshheading:20622363-Gene Expression Profiling,
pubmed-meshheading:20622363-Humans,
pubmed-meshheading:20622363-Lim Kinases,
pubmed-meshheading:20622363-Middle Aged,
pubmed-meshheading:20622363-Neoplasm Staging,
pubmed-meshheading:20622363-Precancerous Conditions,
pubmed-meshheading:20622363-Protein-Serine-Threonine Kinases,
pubmed-meshheading:20622363-Proto-Oncogene Proteins,
pubmed-meshheading:20622363-Survival Rate,
pubmed-meshheading:20622363-Treatment Outcome,
pubmed-meshheading:20622363-Uterine Cervical Neoplasms,
pubmed-meshheading:20622363-Young Adult
|
pubmed:articleTitle |
Expression profiling of G2/M phase regulatory proteins in normal, premalignant and malignant uterine cervix and their correlation with survival of patients.
|
pubmed:affiliation |
Department of Radiotherapy, CSM Medical University, Lucknow, India.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|